Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)

Pediatric-onset multiple sclerosis (POMS) is an immune-mediated, demyelinating, neurodegenerative disease that accounts for 3–5% of all multiple sclerosis (MS) cases. Although evidence suggests that it has similar risk factors and disease pathophysiology as adult-onset MS (AOMS), there are distincti...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jenny, Rensel, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858833/
https://www.ncbi.nlm.nih.gov/pubmed/31814792
http://dx.doi.org/10.2147/PHMT.S220817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858833/
https://www.ncbi.nlm.nih.gov/pubmed/31814792
http://dx.doi.org/10.2147/PHMT.S220817

Ejemplares similares